🔎 Trials Near Me

መነሻ › ሴዛሮች › አሪዞና

በአሪዞና ለሴዛሮች የሚደረጉ ክሊኒካዊ ጥናቶች

ለሴዛሮች የሚደረጉ 7 ጥናቶች በአሪዞና ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በአሪዞና ውስጥ ያሉ ከተሞች

Official study text (English)

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Banner University Medical Center-Phoenix, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07233239

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  • Xenoscience, Phoenix
  • Banner University Medical Center-Phoenix, Phoenix
  • Center for Neurosciences, Tucson
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06798896

Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

  • Mayo Clinic, Scottsdale
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1ለተሳታፊዎች ክፍያ መጠቀስ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07012148

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • Mayo Clinic Arizona Epilepsy Center, Phoenix
  • Banner-University of Arizona Medical Center Tucson Comprehensive Epilepsy Program, Tucson
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁን 2026 · NCT05135091

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • University of Arizona, Tucson
ተሳታዮችን በመፈለግ ላይደረጃ 3
6 Months – 13 Years · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2025 · NCT05121324

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

  • Praxis Research Site, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኤፕሪ 2025 · NCT06908356

Epilepsy Learning Healthcare System (ELHS)

  • Barrow Neurological Institute Comprehensive Epilepsy Center, Phoenix
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ30 ኦገስ 2024 · NCT06265103

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።